文献速递生殖医学

计划性卵母细胞冷冻十余年的临床结局与利用情况

Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation.
PubMed 文献 · Reprod Biomed Online · 2021-07-01

RESEARCH QUESTION: What is the clinical experience of patients who have undergone planned oocyte cryopreservation and oocyte thawing and warming? DESIGN: Retrospective observational cohort study.…

要点

  • 仅7.4%的计划性冻卵患者返回使用卵母细胞。
  • 启动冻融者累积活产率为32.4%。
  • 每次移植临床妊娠率47.5%,活产率39.3%。

核心结论

  • 仅小部分计划性冻卵患者返回使用卵母细胞,其中32%能实现活产。

研究设计与样本

  • 回顾性观察性队列研究,纳入2006年6月至2020年10月单一大规模大学附属生殖中心完成计划性卵母细胞冷冻的全部女性。
  • 排除因医学原因行卵母细胞冷冻的患者,共921例接受计划性卵母细胞冷冻。

主要发现

  • 每次移植的临床妊娠率为47.5%,活产率为39.3%。
  • 启动冻融的患者累积活产率为32.4%。
  • 冷冻时年龄<38岁与≥38岁患者的周期结局无显著差异。
  • 年龄≥40岁患者(n=6)无一用自身冻存卵母细胞成功;10例(14.7%)失败后使用供卵实现活产,其中7/10年龄≥38岁。

临床怎么用

  • counseling计划性冻卵患者时应告知返回使用率低(7.4%)及启动冻融后累积活产率约32.4%。
  • 年龄≥40岁冻卵者预后差,可考虑供卵等备选方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the clinical experience of patients who have undergone planned oocyte cryopreservation and oocyte thawing and warming? DESIGN: Retrospective observational cohort study. All women who completed planned oocyte cryopreservation at a single large university-affiliated fertility centre between June 2006 and October 2020 were identified, including the subset who returned to use their oocytes. Patients who underwent oocyte cryopreservation for medical reasons were excluded. Baseline demographics, oocyte cryopreservation and thawing-warming cycle parameters, and clinical outcomes, were extracted from the electronic medical record. The primary outcome was cumulative live birth rate (LBR), and secondary outcomes were cumulative clinical pregnancy rate (CPR), and CPR and LBR per transfer. Results were stratified by age at time of cryopreservation (<38 and ≥38 years). RESULTS: Of 921 patients who underwent planned oocyte cryopreservation, 68 (7.4%) returned to use their oocytes. Forty-six patients (67.6%) completed at least one embryo transfer. The CPR per transfer was 47.5% and LBR was 39.3%. The cumulative LBR per patient who initiated thawing-warming was 32.4%. Cycle outcomes were not significantly different in patients aged younger than 38 years and those aged 38 years or over. No patient aged 40 years or older (n = 6) was successful with their cryopreserved oocytes. Ten patients (14.7%) who were unsuccessful with their cryopreserved oocytes achieved a live birth using donor oocytes, with most (7/10) of these patients aged 38 years and older. CONCLUSION: Only a small percentage of patients returned to use their oocytes, and 32% of those were able to achieve a live birth.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Leung AQ, Baker K, Vaughan D, et al. Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation. Reprod Biomed Online. 2021. PMID: 34474973. doi:10.1016/j.rbmo.2021.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。